A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The data collected through this pilot study will allow us to increase our understanding of
cancer cachexia and the effect of Eicosapentaenoic Acid (EPA) on cancer cachexia. Our
long-term goal is to improve nutritional treatment and reduce illness in the cancer patient
population.
Phase:
N/A
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute